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ABSTRACT
Loss-of-function (LOF) methods such as RNA in-
terference (RNAi), antisense oligonucleotides or
CRISPR-based genome editing provide unparalleled
power for studying the biological function of genes
of interest. However, a major concern is non-specific
targeting, which involves depletion of transcripts
other than those intended. Little work has been per-
formed to characterize the off-target effects of these
common LOF methods at the whole-transcriptome
level. Here, we experimentally compared the non-
specific activity of RNAi, antisense oligonucleotides
and CRISPR interference (CRISPRi). All three meth-
ods yielded non-negligible off-target effects in gene
expression, with CRISPRi also exhibiting strong
clonal effects. As an illustrative example, we eval-
uated the performance of each method for determin-
ing the role of an uncharacterized long noncoding
RNA (lncRNA). Several LOF methods successfully
depleted the candidate lncRNA but yielded different
sets of differentially expressed genes as well as a
different cellular phenotype upon depletion. Similar
discrepancies between methods were observed with
a protein-coding gene (Ch-TOG/CKAP5) and another
lncRNA (MALAT1). We suggest that the differences
between methods arise due to method-specific off-
target effects and provide guidelines for mitigating
such effects in functional studies. Our recommenda-
tions provide a framework with which off-target ef-
fects can be managed to improve functional charac-
terization of genes of interest.
INTRODUCTION
The ability to specifically reduce the expression of a par-
ticular gene is fundamental for establishing its loss-of-
function (LOF) phenotype in cells and organisms, and
is frequently the only way to infer gene function. The
most commonly used LOF methods are RNA interfer-
ence (RNAi), antisense oligonucleotides and CRISPR in-
terference (CRISPRi) (1). RNAi uses small interfering
RNA molecules to deplete target transcripts by trigger-
ing their degradation (2). Efficient depletion of genes can
also be achieved with antisense oligonucleotides (3); the
most widely used antisense approach involves locked nu-
cleic acids (LNAs) (4), where the presence of the LNAmod-
ification within an RNA:DNA hybrid triggers RNase-H-
mediated degradation of the target transcript in the nu-
cleus (5) or even depletion of the nascent transcript (6).
Most recently, the CRISPR/Cas9 system has been adapted
to inhibit the expression of single genetic locus. Deac-
tivated Cas9 (dCas9) fused to a Kru¨ppel-associated box
(KRAB) repression domain can be directed to a specific ge-
nomic locus to prevent transcription, an approach known
as CRISPR interference (CRISPRi) (7–10). This allows re-
pression of a targeted locus without editing the genome,
thus avoiding unintentional deletion of active regulatory el-
ements (11).
These three approaches have been successfully applied
in the literature to characterize the function of a variety
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of coding and non-coding genes in a range of biological
systems (9,12–19). Of increasing interest is the application
of LOF methods to deplete long noncoding RNAs (lncR-
NAs), of which there are tens of thousands in the mam-
malian genome. Many of these are involved in the regula-
tion of diverse cellular processes and act as key players in
chromatin organisation and (post-)transcriptional gene reg-
ulation (20,21), but the function of the majority of lncR-
NAs is unknown. Indeed, the FANTOM6 project aims to
systematically elucidate the function of lncRNAs in the hu-
man genome using these LOFmethods. However, a number
of studies in the lncRNA field have shown discrepancies be-
tween the cellular and molecular phenotypes obtained with
different depletion methods, even in the same cellular back-
ground (22–28). This raises into question the reliability of
these methods for functional characterization of lncRNAs
and their target genes.
When using any LOF method, a critical consideration is
whether the expression levels of non-target genes are in-
advertently perturbed. These off-target effects arise from
non-specific activity of the knockdown technology when
exposed to the endogenous pool of total RNAs. For ex-
ample, RNAi and antisense oligonucleotides with sufficient
complementarity to non-target transcripts may cause un-
intended repression of those genes (29–33). Widespread
genome binding and modest off-target effects have also
been reported for the dCas9–KRAB system (34,35). How-
ever, to the best of our knowledge, little work has been per-
formed in the literature to characterize the off-target ac-
tivity of each of these commonly used LOF methods at a
transcriptome-wide level.
In this study, we comprehensively quantified the off-
target effects associated with each LOF strategy, with a par-
ticular focus on the transcriptome. Exploiting the HeLa cell
line as a powerful and widely used model for LOF stud-
ies, we performedRNA sequencing (RNA-seq) with a range
of negative controls for each method and used differential
expression analyses between control samples to character-
ize off-target effects. The identities of the genes affected by
off-target activity in RNAi and LNA approaches were no-
tably dependent on the sequences of the siRNA/antisense
oligonucleotides used. Introducing dCas9–KRAB to a
polyclonal population of HeLa cells caused few transcrip-
tional perturbations, with limited sequence-dependent off-
target effects. However, single cell cloning from this popu-
lation resulted in a unique and reproducible transcriptional
signature.
To illustrate the impact that differences between methods
can have on understanding gene function, we show that de-
pletion of lncRNA with unknown function using different
LOF methods can lead to different biological conclusions.
We also demonstrate that discrepancies between methods
are present in the molecular phenotypes generated upon
depletion of a protein-coding gene (Ch-TOG/CKAP5) and
another lncRNA (MALAT1). We suggest that these differ-
ences are caused by method-specific off-target effects, and
provide recommendations to manage these effects based on
our experimental design. This includes the use of multiple
negative controls generated from each step of the protocol,
and the use of a log-fold change threshold during the differ-
ential expression analysis. Our aim is to provide guidelines
with which off-target effects can be mitigated to improve
functional characterization of genes of interest.
MATERIALS AND METHODS
Cell culture
HeLa and HEK293T cells were maintained in Dulbecco’s
modified Eagle’s medium (Sigma Aldrich, D6429) supple-
mented with 10% Fetal bovine serum (FBS, Thermo Fisher
Scientific). Both cell lines were obtained from the Ameri-
can Type Culture Collection (ATCC) and were cultured at
37◦C with 5% CO2. HeLa Kyoto (EGFP--tubulin/ H2B-
mCherry) cells were obtained from Jan Ellenberg (EMBL
Heidelberg) (36) and cultured in DMEM with 10% FBS
(37). All cell lines were verified by short tandem repeat
(STR) profiling and tested negative for mycoplasma con-
tamination.
Single-molecule RNA fluorescent in situ hybridization
(FISH)
Cells were grown on coverslips, briefly washed with PBS
and fixed with PBS/3.7% formaldehyde at room tempera-
ture for 10 min. Following fixation, cells were washed twice
with PBS. The cells were then permeabilised in 70% ethanol
for at least 1 h at 4◦C. Stored cells were briefly rehydrated
withWash Buffer (2× SSC, 10% formamide, Biosearch) be-
fore FISH. The Stellaris FISH Probes (SLC25A25-AS1 ex-
onic probes Q570; sequences in Supplementary Table S4)
were added to the hybridization buffer (2× SSC, 10% for-
mamide, 10% dextran sulfate, Biosearch) at a final concen-
tration of 250 nM. Hybridization was carried out in a hu-
midified chamber at 37◦C overnight. The following day, the
cells were washed twice with Wash Buffer (Biosearch) at
37◦C for 30 min each. The second wash contained DAPI
for nuclear staining (5 ng/ml). The cells were then briefly
washed with 2× SSC and then mounted in Vectashield
(Vector Laboratories, H-1000). Images were captured using
a Nikon TE-2000 inverted microscope with NIS-elements
software, a Plan Apochromat 100x objective and an Andor
Neo 5.5 sCMOS camera.We acquired 25 optical slices at 0.3
m intervals. Images were deconvolved with Huygens Pro-
fessional and projected in two dimensions using ImageJ.
Plasmids and antibodies
Plasmids used in this study were pHR-SFFV-dCAS9-BFP-
KRAB (Addgene, #46911), pU6-sgRNA EF1Alpha-puro-
T2A-BFP (Addgene, #60955), second-generation packag-
ing plasmid psPAX2 (Addgene, #12260) and the enve-
lope plasmid pMD2.G (Addgene, #12259). pHIV-Zsgreen
(Addgene #18121) and LincExpress-mCherry (modified
version of pLenti6.3/TO/V5-DEST, kindly provided by
John Rinn, Harvard University) were used as positive con-
trols for transduction efficiency. Cas9 antibody was ob-
tained from Cell Signaling (#14697, dilution 1:1000) and
-tubulin antibody was purchased from Sigma (#T019, di-
lution 1:2000).
Downloaded from https://academic.oup.com/nar/article-abstract/46/12/5950/5026268
by guest
on 31 July 2018
5952 Nucleic Acids Research, 2018, Vol. 46, No. 12
RNAi- and LNA-mediated gene depletion
HeLa cells were transfected with Lipofectamine RNAiMax
reagent (Thermo Fischer Scientific) following the manufac-
turer’s instructions. All experiments to measure the effect of
depletion were done 48 hours after transfection. The siR-
NAs (Thermo Fischer Scientifc) and LNA Gapmers (Ex-
iqon) were used at a final concentration of 50 nM and
25 nm, respectively. siRNA and LNA sequences are listed
in Supplementary Tables S5 and S6, respectively.
Western blotting
Cells were grown in a six-well plate, trypsinized, pelleted
and washed twice with PBS. The pellet was lysed in lysis
buffer (50 mM Tris–HCl, pH 8, 125 mM NaCl, 1% NP-40,
2 mMEDTA, 1 mM PMSF and protease inhibitor cocktail
[Roche]) and incubated on ice for 25min. Samples were cen-
trifuged for 3 min at 12 000 × g and 4◦C. Supernatant was
collected and protein concentration was determined using
the Direct Detect® Spectrometer (Merck Millipore). Pro-
teins (25 g) were denatured, reduced, and separated with
Bolt® 4–12% Bis–Tris Plus Gel (Thermo Fisher Scien-
tific) in MOPS buffer (Thermo Fisher Scientific, B0001-
02). Proteins were then transferred to nitrocellulose mem-
brane and blocked with 5% nonfat milk in TBS-T (50 mM
Tris, 150 mM NaCl, 0.1% Tween-20) for 1 h at room tem-
perature. Membranes were incubated with primary anti-
bodies in 5% milk in TBS-T. After overnight incubation at
4◦C, the membranes were washed with TBS-T and incu-
bated with HRP secondary antibodies (GEHealthcare Life
Sciences, 1:5000), and immunobands were detected with a
Pierce ECL Western Blotting Substrate Substrate (Thermo
Fischer Scientific, 32106). An uncropped scan of the im-
munoblot (Figure 2) is shown in Supplementary Figure S20.
Time-lapse microscopy
HeLa cells (10 000 cells) were cultured in 8-well chamber
slides (Ibidi) with 200 l/well of normal HeLa medium
(DMEM, 10% FBS). Thirty minutes before live-cell imag-
ing, the medium was replaced with imaging medium
(DMEM fluorobrite, A1896701, Thermo Fisher Scientific,
supplemented with 10% FBS and 4 mM Glutamax) con-
taining 300 nM SiR–Hoechst (Spirochrome, SC007). SiR–
Hoechst was present in the medium throughout imaging
(Figure 4E) while no SiR–Hoechst was used for live-cell
imaging after depletion of Ch-TOG and MALAT1 (Sup-
plementary Figures S1 and S2). HeLa Kyoto cells were
plated in the same way but imaging was performed in
DMEM medium with 10% FBS. Time-lapse microscopy
was performed for both cell lines 48 h after transfection
with RNAi, LNA or CRISPRi transduction. Mitotic dura-
tion was measured as the time from nuclear envelope break-
down (NEBD) until anaphase onset, based on visual in-
spection of the images. Live-cell imaging was performed us-
ing a Zeiss Axio Observer Z1 microscope equipped with a
PLAPO 0.95NA 40× dry objective (Carl ZeissMicroscopy)
fitted with a LED light source (Lumencor) and an Orca
Flash 4.0 camera (Hamamatsu). Four positions were placed
per well and a z-stack was acquired at each position every
10 min for a total duration of 12 h. Voxel size was 0.325 m
× 0.325 m × 2.5 m. Zen software (Zeiss) was used for
data collection and analysis. Throughout the experiment,
the cells were maintained in a microscope stage incubator
at 37◦C in a humidified atmosphere of 5% CO2.
CRISPR interference (CRISPRi) and gRNA design
For CRISPRi, we used published sgRNA sequences in-
cluding two negative control sgRNAs and sgRNAs against
the H19 and MALAT1 lncRNAs (9). We also designed
new sgRNA sequences for depletion of SLC25A25-AS1,
Ch-TOG andMALAT1 (three additional guides). Each se-
quence was 20 nt in length and targeted a genomic win-
dow of −50 to +200 bp relative to the transcription start
site (TSS) (Supplementary Table S7). The location of the
TSS was determined using the NCBI RefSeq database.
The MIT CRISPR (http://crispr.mit.edu) and the gUIDE-
book™ gRNA design (Desktop Genetics Ltd) web tools
were used to design the gRNA sequence. Potential off-
target effects were analysed with the MIT CRISPR and
the CRISPR RGEN Cas-OFFinder web tools to obtain all
genomic sites with no more than 4 mismatches to the in-
put sequence. We used the Basic Local Alignment Search
Tool to determine whether any reported sites were located
within annotated genes other than the intended target, and
if so, the guide sequence was discarded. Additional se-
quences were added to the sgRNA sequences to obtain
compatible sticky ends for cloning the DNA insert into
the 5′BstXI-BlpI3′ digested backbone of a pU6-sgRNA
EF1Alpha-puro-T2A-BFP expression plasmid. gRNA oli-
gos were phosphorylated, annealed and cloned into pU6-
sgRNAEF1Alpha-puro-T2A-BFP expression plasmid. All
inserts were verified with Sanger sequencing.
Lentiviral transduction
To produce lentivirus, 4 × 106 of HEK293T cells were
plated in a 10-cm dish one day prior to transduction. On
the following day, cells were transfectedwith 15g ofDNA,
composed of 9 g of the lentiviral vector DNA containing
the transgene, 4 g of psPAX.2 and 2 g of pMD2.G in a
final transfection volume of 1.5ml (including 45 ul of Trans-
Lt1 transfection reagent, Mirus) using OptiMEM medium
(Thermo Fisher Scientific). As a positive control for viral
infection and to control for any possible effects of lentivi-
ral delivery, we transduced cells with polybrene (5 g/ml,
Sigma) or with pHIV-Zsgreen and LincExpress-mCherry
vectors. The transfection mixture was incubated for 25 min
at room temperature. Prior to transfection, oldmediumwas
replaced by 14ml of freshmedium and transfectionmix was
added dropwise to the cells and incubated for 24 h at 37◦C.
The following day, oldmediumwas replaced by 7ml of fresh
medium and incubated for another 24 h at 37◦C. Viral su-
pernatant was collected 48 and 72 h post transfection, spun
down at 1800 × g for 5 min at +4◦C, and filtered through
a 45 m filter. Ready-to-use virus was stored at +4◦C. For
long-term storage, viral supernatant was frozen at −80◦C.
FACS analysis and cell sorting
HeLa cells were transduced with lentivirus containing
the pHR-SFFV-dCAS9-BFP-KRAB vector together with
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polybrene (5 g/ml, Sigma). Twenty four hours after
lentivirus transduction, the medium was replaced and the
cells were incubated for another 48 hours. HeLa cells were
then sorted for the BFP-expressing cells using the BD FAC-
SAria III cell sorter (CRUK Flow Cytometry Core Facil-
ity). The expression of BFP fluorescent proteins was de-
tected using MACSQuant VYB (Miltenyi Biotec) and the
data were analysed using the FlowJo v7.1 software. BFP-
sorted HeLa cells were used for single cell cloning in 96-well
plate (clonal cells) or to create a stable non-clonal cell pop-
ulation.
CRISPRi-mediated depletion
Three to four days after FACS sorting, dCas9–KRAB
transduced cells were plated on 12-well plates and infected
with lentivirus containing gRNAs targeting SLC25A25-
AS1, MALAT1, Ch-TOG or H19, or with lentivirus con-
taining one of two negative guide RNAs. Lentivirus was di-
luted with HeLa medium (1:1 dilution) and cationic poly-
mer polybrene was added to facilitate viral transduction
(5 g/ml, Sigma, H9268). After a 24 h incubation, super-
natant was removed and fresh medium was added for an-
other 48 hour incubation before RNA collection to evalu-
ate knockdown of the target gene. Non-transduced cells did
not receive virus and were used as a negative control.
RNA extraction, cDNA and quantitative real-time PCR
(qPCR)
RNA (1 g) was extracted with the RNeasy Kit (QIA-
GEN, 74106) and treated with DNase I following the man-
ufacturer’s instructions (QIAGEN, 79254). The QuantiTect
Reverse Transcription Kit (QIAGEN, 205313) was used
for cDNA synthesis including an additional step to elimi-
nate genomic DNA contamination. Quantitative real-time
PCR (qPCR) was performed on a 7900HT Fast Real-Time
PCR System (Applied Biosystems) with Fast SYBR Green
Master Mix (Life Technologies). Thermocycling parame-
ters were defined as 95◦C for 20 s followed by 40 cycles of
95◦C for 1 s and 60◦C for 20 s. Two reference genes (GAPDH
and RPS18) were used to normalise expression levels using
the 2−CT method. Sequences of qPCR primers are pro-
vided in Supplementary Table S8.
Subcellular fractionation
RNA was fractionated as described previously (38,39).
Briefly, cells from a 150-mm dish were used to isolate RNA
from cytoplasmic, nucleoplasmic and chromatin fractions
by TRIZOL extraction (Life Technologies). Expression of
target genes in each fraction was analysed by qPCR. Data
were normalised to the geometric mean of GAPDH and
ACTB levels in each cellular compartment. MALAT1 and
RPS18were used as positive controls for chromatin and cy-
toplasmic fractions, respectively.
RNA library preparation, sequencing and analysis
RNA-seq libraries were prepared from HeLa cells us-
ing the TruSeq Stranded Total RNA Kit with Ribo-Zero
Gold (Illumina, RS-122-2303). We generated four biolog-
ical replicates of cell populations after RNAi, LNA and
CRISPRi-mediated depletion of SLC25A25-AS1 or H19
with an equal number of replicates for the correspond-
ing negative controls. Indexed libraries were PCR-amplified
and sequenced using 125 bp paired-end reads on an Illu-
mina Hiseq 2500 instrument (CRUK Genomics Core Fa-
cility). In addition, two biological replicates were generated
for RNAi- and LNA-mediated depletion of Ch-TOG and
MALAT1 respectively, while three biological replicates were
generated for CRISPRi-mediated depletion ofCh-TOG and
MALAT1. These libraries were sequenced using 150 bp
paired-end reads on an Illumina Hiseq 4000 instrument
(CRUK Genomics Core Facility). Each library was se-
quenced to a depth of 20–30 million read pairs. Paired-end
reads were aligned to the hg38 build of the human genome
(40) and the number of read pairs mapped to the exonic re-
gions of each gene was counted for each library (41). Ap-
proximately 80% of read pairs contained one read that was
successfullymapped to the human reference genome.On av-
erage, 74% of all read pairs in each library were assigned
into exonic regions and counted. Any outlier samples with
very low depth (resulting from failed library preparation or
sequencing) were removed prior to further analysis. Differ-
ential gene expression analyses were performed using the
voom-limma framework (42), where we tested for differen-
tial expression above a log2-fold change threshold of 0.5 in
pairwise contrasts between groups of samples (43). For each
contrast, genes with significant differences in expression be-
tween groups were detected at a false discovery rate (FDR)
of 5%.
Determination of noncoding potential of lncRNAs
The Coding-Potential Calculator (CPC) ((44), http://
cpc.cbi.pku.edu.cn) and the Coding Potential Assess-
ment Tool (CPAT) ((45), http://lilab.research.bcm.edu/cpat/
index.php) were used to determine noncoding potential.
LncRNAs with CPC score >1 and CPAT score >0.364
were predicted to have protein-coding capacity. The Phy-
loCSF score was taken from UCSC (https://github.com/
mlin/PhyloCSF/wiki, (46)).
Statistical analysis
The statistical significance of differences between groups
was determined by two-tailed Student’s t-test in all exper-
iments using GraphPad Prism unless indicated otherwise.
P-values> 0.05 were considered statistically not significant.
The differential expression analysis of the RNA-seq data is
described in detail in the Supplementary Methods.
RESULTS
LNA and RNAi technologies are associated with non-
negligible off-target effects
We first verified that the RNAi and LNA methods were
able to deplete both protein-coding genes and lncRNAs.
We successfully depleted Ch-TOG/CKAP5, a microtubule-
associated protein required for mitotic spindle assembly, us-
ing a pool of four different siRNAs (Supplementary Fig-
ure S1A). We were able to recapitulate the well-established
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Figure 1. Off-target effects associated with RNAi and LNA oligonu-
cleotides. (A) Comparison of the transcriptional differences between un-
treated cells, cells treated with transfection reagent (RNAiMax) and two
negative control siRNAs (Ambion and GE Dharmacon). The number of
DEGs between each pair of treatments is labelled and shown as connect-
ing lines of proportional thickness. (B) Comparison of the transcriptional
differences between untreated cells, cells treated with transfection reagent
(RNAiMax) and two negative control LNAs (A and B). The number of
DEGs differing between each pair of treatments is labelled as described
in A. DEGs for each pairwise comparison were defined at an FDR of 5%
testing for a log2-fold change significantly greater than 0.5. Lists of DEGs
for each comparison are shown in Supplementary Table S1. Note that the
comparison between cells treated with transfection reagent and untreated
cells is the same between A and B.
cellular phenotype of mitotic delay upon Ch-TOG deple-
tion (Supplementary Figure S1B and C) (47,48). For LNA
oligonucleotides, we noted that they have mostly been used
to deplete nuclear lncRNAs (16,26,49). Thus, to verify their
effectiveness, we used LNA oligonucleotides to efficiently
deplete MALAT1 (Supplementary Figure S2A and B), a
highly conserved nuclear lncRNA with roles in regulating
gene expression, RNA processing and alternative splicing
(50–52). Depletion ofMALAT1 in HeLa cells led to mitotic
delay (Supplementary Figure S2C and D) as described pre-
viously (26). Thus, both technologies were able to deplete
target genes at high efficiency and recapitulate the associ-
ated cellular phenotypes.
We then performed RNA-seq on untreated cells, cells
treated with transfection reagent alone, or cells treated with
one of two negative control siRNAs (Ambion and GE
Dharmacon) (Figure 1A). In principle, treatment with the
negative control siRNAs should have no effect on gene ex-
pression, as no gene is targeted for depletion. Thus, our ex-
perimental design allows us to quantify the transcriptional
off-target effects of the two negative control siRNAs, based
on the number of differentially expressed genes (DEGs)
when compared to cells treated with transfection reagent.
We identified 8 (GEDharmacon) and 53 genes (Ambion)
affected by the introduction of each negative control siRNA
at a FDR of 5% (Figure 1A, Supplementary Figure S3),
some of which we validated by qPCR (Supplementary Fig-
ure S4A). Of these, five genes were affected by both nega-
tive control siRNAs, likely representing a general effect of
siRNA transfection (Supplementary Figure S4B). The off-
target genes affected by either of the negative control siR-
NAs were not obviously associated with a functional path-
way. No single KEGG term contained more than 20% of
the DEGs (Supplementary Figure S5A and B, Supplemen-
tal Table S1), with most terms containing less than 10%.
These results indicate that off-target genes associated with
addition of negative control siRNAs do not fall into path-
ways that would be easy to computationally predict or re-
move.
We further identified DEGs between cells treated with
negative control siRNA from Ambion and those treated
with the negative control siRNA from GE Dharmacon. In
this comparison, only the siRNA sequence differs between
the two controls––thus, any DEGs between the controls
must represent sequence-dependent off-target effects, rather
than a general effect of siRNA transfection. Comparison
between the negative control treatments yielded 55 DEGs,
indicating that the perturbations due to non-specific target-
ing are dependent on the exact sequence of the siRNA used
to treat the cells. Again, no common function for this set of
DEGs was detectable by KEGG pathway analysis (Supple-
mentary Figure S5C, Supplemental Table S1), with fewer
than 10% of DEGs associated with any KEGG term.
We also generated transcriptomic profiles for negative
controls at each step of the depletion protocol using LNA
Gapmers (Exiqon). Treating cells only with transfection
reagent led to perturbation of 30 genes (Figure 1B, Sup-
plementary Figure S6) compared to untreated cells. Treat-
ment using either of two different negative control LNAs
yielded zero (control LNA A, Exiqon part number 300611-
00) and 112 (control LNA B, Exiqon part number 300615-
00) DEGs compared to the transfection control, some of
which we validated by qPCR (Supplementary Figure S7A).
Comparison between the two negative control LNAs iden-
tified 89 DEGs. Applying the same reasoning as described
above for RNAi, these 89 genes represent the sequence-
dependent off-target effects of the LNA approach. Similar
to RNAi, KEGG pathway analysis of off-target effects us-
ing negative LNAcontrols did not reveal any common func-
tion for the DEGs (Supplementary Figure S7B and C; Sup-
plementary Table S1).
We note that our DE analyses used a log-fold change
threshold of 0.5 based on the TREATmethod (43). This pri-
oritizes the detection of genes with large log-fold changes in
expression that are more likely to perturb the biology of the
cell. For comparison, we repeated our analysis without any
log-fold change threshold, which resulted in over an order
of magnitude increase in the number of DEGs in most com-
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parisons between negative controls (Supplementary Figure
S8A and B). This motivates the use of a threshold in ourDE
analysis, to avoid having to consider a much larger number
of genes with small log-fold changes that are only weakly
affected by off-target activity.
In summary, a non-negligible number of genes are af-
fected by off-target activity with bothRNAi and LNA tech-
nologies. The sequence-dependent nature of the off-target
effects has important implications for how these methods
can be used to study transcriptional regulation. In particu-
lar, it strongly suggests that generic negative controls cannot
accurately recapitulate non-specific changes in expression
that arise when targeting a particular gene.
CRISPRi with single cell cloning introduces transcriptional
variation
CRISPRi-mediated transcriptional inhibition can target
gene expression using both non-clonal (9,10,13,14) and
single cell derived clonal populations (14,53). To directly
compare CRISPRi with other LOF methods, we generated
HeLa cells expressing dCas9–KRAB using lentiviral trans-
duction, and confirmed the expression of dCas9–KRAB in
both clonally isolated populations of cells and non-clonally
isolated populations (Figure 2A).We verified that CRISPRi
was effective at repressing expression of Ch-TOG (Supple-
mentary Figure S9A) and recapitulated the mitotic pheno-
type (Supplementary Figure S9B and C), albeit with greater
heterogeneity than the phenotype observed with RNAi.
We then transduced one CRISPRi clone (CRISPRi clone
2) and a non-clonal cell population with two negative con-
trol guide RNAs (negative control guide 1 or 2). We per-
formed RNA-seq to quantify the off-target effects by com-
paring the transcriptional profiles before and after treat-
ment with each of the negative control guides. The addi-
tion of the negative guide RNAs had large effects in the
clonal CRISPRi cells (103 and 106 genes in Figure 2B, Sup-
plementary Figure S10) and minor effects in the non-clonal
CRISPRi cells (1 and 8 genes in Figure 2C, Supplementary
Figure S11). However, only two genes were differentially ex-
pressed between the negative guide RNAs in each CRISPRi
strategy. This indicates that the sequence-dependent off-
target effects of CRISPRi are minor, consistent with pre-
vious studies suggesting that CRISPRi-mediated gene re-
pression is highly specific (8). Thus, comparisons between
cells treated with different guide RNAs (negative control or
targeting a specific gene) can be safely performed.
Single cell cloning after introduction of dCas9–KRAB
provides another potential source of off-target effects.
We found 201 DE genes between the parental HeLa
cells and clonally-derived cells expressing dCas9–KRAB
in the absence of a guide RNA (Figure 2B). To inves-
tigate whether the single cell dilution protocol for ob-
taining dCas9–KRAB-expressing clones could be respon-
sible for the changes in genes expression, we profiled addi-
tional CRISPRi clones expressing different levels of dCas9–
KRAB (clones 1 and 3; Figure 2D) along with additional
independent replicates of CRISPRi clone 2. We detected
a core set of 37 DE genes that were consistently differ-
entially expressed in all three clones compared to non-
transduced control cells (Figure 2D and E). We did not ob-
serve any common pathway for these 37 genes using KEGG
analyses (Supplementary Figure S12, Supplementary Ta-
ble S1) and found no relationship between these genes and
their chromosomal location (Supplementary Figure S13).
Most of the genes (33 out of 37) were downregulated in all
clones, suggesting that they could be direct targets of the
repressive KRAB domain. We validated the repression of
two of these 37 genes (SCIN and CDH2) by qPCR (Fig-
ure 2F). Importantly, these changes in gene expression are
not caused by lentiviral transduction (Supplementary Fig-
ure S14). Rather, they are caused by single cell cloning,
given that the corresponding comparison between parental
HeLa cells and non-clonal cells in the absence of any guide
RNA yielded only 3 DEGs (Figure 2C, Supplementary Fig-
ure S15C). Thus, stable expression of dCas9–KRAB causes
marked changes in the transcriptomic background prior to
the depletion of gene of interest.
Widespread genome binding and modest off-target ef-
fects have been reported for the dCas9–KRAB system
(34,35,54). Therefore, we compared the published binding
sites for dCas9 in HEK293T cells (55) with the gene bodies
for our core set of 37 differentially expressed genes (Figure
2E) and found no overlap. We performed a similar anal-
ysis using the genome-wide mapping of dCas9–KRAB in
K562 cells (35) and found only two dCas9–KRAB binding
events in these 37 genes. We also found no overlap between
our core set of genes with those reported as being differ-
entially expressed upon dCas9–KRAB transduction (35).
These poor overlaps may reflect the potential dependency
of CRISPRi off-target effects on the cell type, the epige-
netic landscape, or other factors (56). More generally, our
results suggest that a common blacklist for in silico removal
of likely affected genes is unlikely to be effective. The ab-
sence of a consistent set of genes across three independent
studies that have attempted to identify common CRISPRi
off-targets suggests that purely computational approaches
may not be able to account for off-target effects a priori.
A case study in using LOF methods to deplete a nuclear long
noncoding RNA
We applied these three LOF methods––RNAi, LNA
oligonucleotides and CRISPRi––to study the regulatory
function of a previously uncharacterized lncRNA in HeLa
cells. This represents a common use of LOF strategies, given
that tens of thousands of uncharacterized lncRNAs exist in
the mammalian genome (57,58). Previous studies have suc-
cessfully depleted lncRNAs using RNAi (12,15,38,59–62),
LNAs (6,12,16,17,26,61) and CRISPRi (6,9,12,14,61,63) to
determine their functions.
We selected a prototypical lncRNA following published
guidelines (11) with specific characteristics, including: (i)
previously uncharacterized, (ii) consistently expressed at
more than one molecule per cell, (iii) low coding poten-
tial, (iv) chromatin hallmarks of active transcription and
(v) nuclear localization. Using these criteria, we chose
SLC25A25-AS1 (also known as loc100289019) as a spliced
and intragenic lncRNA with three promoters and a sin-
gle 3′ polyadenylation site (Figure 3A). Among all EN-
CODE cell lines, SLC25A25-AS1 was most highly ex-
pressed in the nucleus of HeLa cells (Figure 3B). We con-
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Figure 2. Clonal variations in CRISPRi and their associated off-target transcriptional effects. (A) Expression in counts-per-million (CPM) of Cas9 in
CRISPRi clonal, CRISPRi non-clonal and untransduced HeLa cells. Clone 2 was used for showing Cas9 expression in CRISPRi clonal cells. (B) Com-
parison of the transcriptional differences between parental HeLa untreated cells, CRISPRi clones expressing only dCas9–KRAB (clone 2) and clones
treated with two negative guide RNAs (negative guide 1 and 2). The number of genes differing between each pair of treatments is labelled and shown as
connecting lines of proportional thickness. (C) Comparison of the transcriptional differences between parental HeLa untreated cells, non-clonal CRISPRi
cells expressing dCas9–KRAB and non-clonal cells treated with two negative guide RNAs (negative guide 1 and 2). The number of genes differing between
each pair of treatments is labelled as described in B. (D) Expression of dCas9–KRAB in three different CRISPRi clones derived from single cell cloning,
confirmed by immunoblot using a Cas9 antibody. -tubulin was used as a loading control. A Venn diagram of DEGs detected in the three different clones
against untransduced cells in the absence of any guide RNAs identified 37 genes as a common transcriptional signature of cloning. The total number of
genes in this analysis was 18224 and DEGs were detected at a FDR of 5% with a log2-fold change threshold of 0.5. (E) Heat map of DEGs from three
different CRISPRi clones compared to non-clonal cells and parental untransduced HeLa cells in the absence of any guide RNAs. 33 out of 37 genes were
downregulated in clonal cells compared to the parental population. (F) Downregulation of two randomly selected DEGs from E (SCIN and CDH2) was
validated by qPCR in clonal cells (clone 2) and in non-clonal populations. Expression levels were normalized to the geometric mean of GAPDH and
RPS18. Error bars, s.e.m. (n = 4 biological replicates). Statistical significance by two-tailed Student’s t-test: *P < 0.05, **P < 0.01, ***P < 0.001 and
****P < 0.0001. Lists of DEGs for each pairwise comparison in B and C are provided in Supplementary Table S1.
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Figure 3. SLC25A25-AS1 is an archetypal lncRNA expressed in the nucleus. (A) Schematic representation of the genomic landscape surrounding
SLC25A25-AS1 (annotated inRefSeq as loc100289019; chr9:128108581-128118693, hg38), including three transcriptional start sites (101) and a polyadeny-
lation site (102). SLC25A25-AS1 is not occupied by ribosomes (64), shows no protein coding potential (PhyloCSF, (46)), and has clear hallmarks of active
transcription in HeLa cells (H3K4me3 and H3K27ac data sets obtained from ENCODE via the UCSC browser). The arrows denote the direction of
transcription, and green boxes represent the five exons. Note that all PhyloCSF scores at this locus are negative. (B) Expression of SLC25A25-AS1 in
cytosol and nuclei of ENCODE cell lines (www.ebi.ac.uk/gxa/home), shown as reads per kilobase of exon per million reads mapped (RPKM). (C) Compu-
tational analysis of the mature SLC25A25-AS1 transcript using the CPC and CPAT tools reveals SLC25A25-AS1 has low coding potential. (D) Nuclear
localization of SLC25A25-AS1 in HeLa cells was determined using single-molecule RNA FISH with exonic probes (green). Nuclei were stained with
4,6-diamidino-2-phenylindole (DAPI). Scale bar represents 5 m. (E) SLC25A25-AS1 is enriched in chromatin of HeLa cells. RNA distribution in the cy-
toplasm, nucleoplasm and chromatin was quantified by qPCR, andRPS18 andMALAT1were used as positive controls for the cytoplasmic and chromatin
fraction, respectively. Error bars represent the standard error of the mean (s.e.m) values of four independent experiments.
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firmed that SLC25A25-AS1 has low protein coding poten-
tial using PhyloCSF, Coding-Potential Calculator (CPC)
and Coding-Potential Assessment Tool (CPAT) (Figure
3C). Furthermore, computational analysis of previously
published ribosomal occupancy data indicated no transla-
tion of the SLC25A25-AS1 transcript in HeLa cells (64)
(Figure 3A, Riboseq track). Nevertheless, the genomic lo-
cus was actively transcribed based on the presence of both
histone H3 lysine 4 trimethylated (H3K4me3) and histone
H3 lysine 27 acetylated (H3K27ac) histones at the predicted
SLC25A25-AS1 locus (Figure 3A). We experimentally con-
firmed nuclear localization of SLC25A25-AS1 by single-
molecule RNA FISH (Figure 3D), and demonstrated by
cellular fractionation that SLC25A25-AS1 is enriched in
chromatin (Figure 3E). We note that the vast majority of
the lncRNAs currently under active investigation satisfy our
selection criteria above. This suggests that our experimental
design using these three LOFmethods is applicable to most
studies of lncRNA function.
We then used the different LOF methods to identify the
transcript(s) robustly regulated by SLC25A25-AS1, regard-
less of the method used for depletion. Only modest reduc-
tion of SLC25A25-AS1 levels was observed when the pool
of four siRNA sequences was used (Figure 4A). This is in
agreement with a previous study showing limited effective-
ness of RNAi for depleting nuclear lncRNAs (16). In con-
trast, we were able to obtain LNA oligonucleotides and
CRISPRi guides that achieved over 50% depletion (Figure
4A, B; Supplementary Figure S16). As such, we discarded
theRNAi results and attempted to identify a common set of
DEGs that were detected with LNA and CRISPRi (clonal
and non-clonal cells). The only transcript common to these
methodswasSLC25A25-AS1 itself (Figure 4C, Supplemen-
tary Table S2). However, the depletion of SLC25A25-AS1
with LNA resulted in hundreds of DEGs, whereas fewer
DEGs were observed with CRISPRi-based methods.
The fact that SLC25A25-AS1 is the only gene transcrip-
tionally impacted by depletion with LNA and CRISPRi
suggests two possible explanations for our results: (i)
SLC25A25-AS1 has no function in transcriptional regula-
tion, the lack of detection with the CRISPRi-based meth-
ods is correct, and the DE genes identified with LNA
knockdown are off-target effects; or (ii) SLC25A25-AS1
does regulate the transcription of other genes, the LNA
method correctly identifies its downstream targets, and the
CRISPRi-based methods are somehow failing to recapit-
ulate the effect. These two explanations are mutually ex-
clusive and cannot be easily distinguished, as the underly-
ing problem stems from the deficiencies of our experimental
tools for perturbing the biological system.
We also examined whether the observed transcriptional
changes result in a cellular phenotype upon SLC25A25-
AS1 knockdown in HeLa cells. We noticed that two
of the top DEGs upon LNA-mediated knockdown of
SLC25A25-AS1, namely SEPTIN2 and GM130 (Figure
4D), had known roles in mitosis (65,66). Depletion of
SEPTIN2 leads tomitotic delay and incomplete cytokinesis
whereas inhibition of GM130 function by antibody injec-
tion leads to mitotic delay and multipolar division. There-
fore, we assayed if mitotic delay also occurred as a result
of SLC25A25-AS1 depletion. To investigate this, we quan-
tified the time required for HeLa cells to transition through
mitosis before and after knockdown ofSLC25A25-AS1.We
observed a significant mitotic delay after LNA-mediated
knockdown of SLC25A25-AS1 (Figure 4E), whereas no
such effect was observed with the CRISPRi-basedmethods.
We further confirmed the mitotic delay with an additional
LNA oligonucleotide (Figure 4F) in HeLa Kyoto cells, a
cell line stably expressing EGFP- tubulin and mCherry-
histone H2B (36). This demonstrates that the differences in
the genes disrupted by each method have real consequences
on the inferred biological function. Using LNA oligonu-
cleotides, one might conclude that SLC25A25-AS1 regu-
lates mitosis, whereas the same conclusion cannot be made
with CRISPRi.
Evaluation of on-target activity for each LOF method with
protein-coding and non-coding genes
We also performed RNA-seq to determine the tran-
scriptional effect of depleting Ch-TOG with RNAi and
CRISPRi. As previously mentioned, we achieved strong de-
pletion and successfully recovered a well established mitotic
phenotype with both LOF methods (Supplementary Fig-
ures S1 and S9). As Ch-TOG represents a target gene with
an essential role in cell division, its depletion should result in
a large number of DEGs driven by biology rather than off-
target effects. Depletion with RNAi resulted in 693 DEGs
compared to the negative control (GE Dharmacon) while
depletion ofCh-TOGwith CRISPRi yielded 87DEGs com-
pared to a negative guide control (Figure 5A; Supplemen-
tary Figure S17A, B; Supplementary Table S3). However,
only 20 DEGs were detected with both methods, and of
these, only five changed in the same direction - one of which
was Ch-TOG itself. This is close to the expected number of
shared genes between the two sets (2.8 genes) if DEGs were
randomly sampled from the pool of all genes, indicating that
there is no common transcriptional signature afterCh-TOG
knockdown. Such a result is unexpected as depletion with
both CRISPRi andRNAi yield the expectedmitotic pheno-
type, yet the twomethods result in DEG sets that are almost
mutually exclusive.
We observed similar RNA-seq results after deple-
tion of MALAT1 with LNAs and CRISPRi. One LNA
oligonucleotide (positive control, antisense LNA Gap-
mer LG00000003, Exiqon) was able to effectively deplete
MALAT1 (Supplementary Figure S2B), recapitulating a
previously described role of MALAT1 in mitotic progres-
sion (26) (Supplementary Figure S2C and D). By com-
parison, none of the CRISPRi guides that we tested (five
in total) achieved >50% knockdown (Supplementary Fig-
ure S18). Unsurprisingly, we detected more DEGs with
LNA-mediated depletion compared to the most effective
CRISPRi guide (guide 84) (Figure 5B, Supplementary Fig-
ure S17C, D; Supplementary Table S3). However, depletion
with CRISPRi still yielded a comparable number of DEGs,
none of whichwere present in the set ofDEGs detected after
depletion with LNA approach. These results are consistent
with the discrepancies between the LOF methods that were
observed for SLC25A25-AS1 and Ch-TOG, and are most
easily explained by strong sequence-dependent off-target ef-
fects in either or both LOF methods being compared for
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Figure 4. No overlap in DEGs between the different LOF methods upon depletion of SLC25A25-AS1. (A) Expression levels of SLC25A25-AS1 after
RNAi, LNA and CRISPRi-mediated depletion. qPCR revealed only a 25% reduction in SLC25A25-AS1 transcription after siRNA-mediated knockdown
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each gene. As we have discussed for lncRNA SLC25A25-
AS1, though, it is not straightforward to determine which
LOF method is correct. Indeed, the largest source of vari-
ability in expression across our entire dataset was the de-
pletion technology (namely, the effect of single cell cloning
in CRISPRi), rather than the target gene that was depleted
(Figure 6).
We also used CRISPRi alone to deplete H19, a multi-
functional and well-characterized lncRNA with activity in
the nucleus and in the cytoplasm (67,68). Knockdown effi-
ciency was similar in clonal and non-clonal cells (Supple-
mentary Figure S19A), though there were modest differ-
ences in the number of DEGs by RNA-seq. Specifically, we
observed 5 and 29 DEGs in clonal and non-clonal popula-
tions, respectively, compared to cells treated with negative
guides (Supplementary Figure S19B; Supplementary Table
S3). This difference hints at the presence of compensatory
mechanisms in clonal cells that may be countering dCas9–
KRAB activity, possibly due to changes in the transcrip-
tional background (Supplementary Figure S15B). We also
examined the expression of genes previously reported to be
regulated byH19 from experiments using RNAi in different
human cell lines (69–71) or genetic deletion in mice (72),
but we observed no evidence of differential expression for
these genes in HeLa cells after H19 depletion (Supplemen-
tary Figure S19C). This highlights another challenge in us-
ing LOFmethods to infer the function of lncRNAs, as they
often operate in a cell type-specific manner (14,26).
DISCUSSION
Here, we systematically compared three widely used LOF
methods and evaluated the transcriptome-wide changes
attributable to each individual method. We describe off-
target effects associated with each LOF method that need
to be considered when investigating gene function, consis-
tent with previous studies (29–31,33–35,54,73). In particu-
lar, we identified large off-target effects in the RNAi and
LNAmethods, which were highly dependent on the siRNA
or LNA oligonucleotide sequence. While CRISPRi was less
sensitive to the guide sequence, the introduction of dCas9–
KRABprovides another source of off-target effects that can
significantly change the transcriptional context in the de-
pleted cells. Single cell cloning of dCas9–KRAB-expressing
cells results in strong transcriptional changes even in the
absence of guide RNAs, indicating that polyclonal popu-
lations should be used for CRISPRi experiments.
Our results suggest that CRISPRI in non-clonal popula-
tions of dCas9–KRAB-expressing cells provides the clean-
est depletion of the target gene, with the fewest off-target
effects (sequence-dependent or otherwise). This is consis-
tent with previous studies demonstrating the superiority
of CRISPRi compared to RNAi (8,14,73,74). However,
CRISPRi has a number of limitations, especially for in-
vestigating the function of lncRNAs. Currently, CRISPRi
can not differentiate cis- and trans-acting functions of RNA
transcripts (21), cis-mediated regulation related to lncRNA
transcription (75–77) and/or enhancer-like functions of
some lncRNA loci (78–80). In addition, CRISPRi is not
ideal for targeting bidirectional promoters (81) or lncRNAs
near other transcriptional units (82), as neighboring genes
may be unintentionally repressed. The other LOF meth-
ods also have their own specific shortcomings––for exam-
ple, RNAi is known to be less effective for targeting nuclear
lncRNAs (16), while LNA oligonucleotides are expensive
and multiple sequences need to be tested to obtain at least
one with high knockdown efficiency.
Differences between the three LOF methods can lead to
significant differences in the molecular or cellular pheno-
type after depletion of a gene of interest, as observed in
our case study with the lncRNA SLC25A25-AS1. This is
consistent with previous studies that performed depletion
of lncRNAs in in vitro and in vivo models with different
technologies. Depletion of lincRNA-p21 using genetic dele-
tion and RNAi showed no overlap in the sets of differen-
tially expressed genes even in the same cell line (22,23), lead-
ing to different conclusions. Indeed, lincRNA-p21 was pro-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
relative to negative control siRNA from Dharmacon (Control Dharm), and no significant difference relative to negative control siRNA from Ambion
(Control Ambion). LNA-mediated knockdown of SLC25A25-AS1 was performed using LNA oligonucleotide sequence 2 (LNA 2), and showed 90%
reduction. CRISPRi-mediated repression of SLC25A25-AS1 using two guide RNAs targeting the TSS of SLC25A25-AS1 relative to the negative (non-
targeting) guide RNA 2 yielded 70–90% knockdown in clonal cells. Only one guide RNA (guide 9) was efficient in depleting SLC25A25-AS1 in non-clonal
cells. Statistical significance by two-tailed Student’s t-test: **P < 0.01, ***P < 0.001 and ****P < 0.0001. For all graphs, expression levels of SLC25A25-
AS1 were measured by qPCR using primers spanning exons 1–4, and normalized to the geometric mean of GAPDH and RPS18. Error bars, s.e.m. (n =
4 biological replicates). (B) Volcano plots of transcriptional differences induced by RNAi, LNA and CRISPRi-mediated depletion of SLC25A25-AS1.
After siRNA-mediated depletion of SLC25A25-AS1, seven genes were differentially expressed compared to the negative control siRNAs. LNA-mediated
depletion with LNA 2 identified 370 DEGs compared to negative control oligonucleotides. CRISPRi-mediated depletion of SLC25A25-AS1 using guide
RNA1 and 9 revealed only twoDEGs compared to negative guideRNA2. In non-clonal cells, only fourDEGswere identified using guideRNA9 compared
to the negative guides. The red horizontal line represents the significance threshold corresponding to an FDR of 5%. Red vertical lines are log2-fold change
thresholds of ±0.5. The red dot corresponds to the SLC25A25-AS1 itself. (C) Venn diagram showing no overlap between the sets of DEGs identified after
using LNA and CRISPRi to deplete SLC25A25-AS1. The only gene in common between LNA and CRISPRi-mediated depletion is SLC25A25-AS1 itself.
The total number of genes used for this analysis was 18224. (D) qPCR confirmation of the downregulation of twoDEGs (SEPTIN2 andGM130) identified
in B after LNA-mediated depletion of SLC25A25-AS1 with LNA 2. Expression levels were normalized to the geometric mean of GAPDH and RPS18.
Error bars, s.e.m. (n = 3 biological replicates). Statistical significance by two-tailed Student’s t-test: ****P < 0.0001. (E) Quantification results from time-
lapse microscopy of mitotic progression of HeLa cells incubated with Sir-Hoechst after LNA and CRISPRi-mediated (clonal and non-clonal) depletion of
SLC25A25-AS1. Mitotic duration was measured from nuclear envelope breakdown (NEBD) to anaphase onset. Bars show mean±s.d. (n= 2 independent
biological replicates). Statistical significance byMann–Whitney test: ****P< 0.0001. (F)Left panel: Expression analysis of SLC25A25-AS1 by qPCRusing
two additional LNAs targeting SLC25A25-AS1 (LNA 1 and LNA 3). Expression levels were normalized to the geometric mean of GAPDH and RPS18.
Error bars, s.e.m. (n = 3 biological replicates). Statistical significance by two-tailed Student’s t-test: ****P < 0.0001. Right panel: Quantification results
from time-lapse microscopy using HeLa Kyoto cells after depletion of SLC25A25-AS1 using three different LNAs. Bars show mean±s.d. (n= 2 biological
replicates). Statistical significance byMann–Whitney test: ****P< 0.0001. The list ofDEGs identified after RNAi, LNAandCRISPRi-mediated depletion
of SLC25A25-AS1 are shown in Supplementary Table S2.
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Figure 5. Comparison of DEGs detected upon depletion of well-characterized target genes with different LOFmethods. (A) Log2-fold changes of all genes
upon depletion of Ch-TOG with CRISPRi (compared to negative guide 2), plotted against the log2-fold changes upon depletion with RNAi (compared
to negative control siRNA Dharmacon). DEGs in each comparison are highlighted. (B) Log2-fold changes of all genes upon depletion ofMALAT1 with
CRISPRi (compared to negative guide 2) plotted against the log2-fold changes upon depletion with LNA (compared to negative control LNAA). DEGs in
each comparison are highlighted. In all comparisons, DEGs were defined at a FDR of 5% after testing for a log2-fold change significantly greater than 0.5.
Lists of DEGs for each comparison are shown in Supplementary Table S3.
posed to function as a trans-acting lncRNA (22), cis-acting
lncRNA (23) or even as an enhancer-like lncRNA (83). Fur-
thermore, genetic deletion of the lncRNA megamind in ze-
brafish did not reproduce themegamind phenotype induced
with morpholinos (24,25). Knockdown ofMALAT1 using
antisense oligonucleotides or RNAi had different effects
on cell growth and cell cycle (27,50). Even more disturb-
ing is the fact that none of these phenotypes were found
inMALAT1 knockout mice (51), suggesting that the func-
tion ofMALAT1 is yet to be fully elucidated (85). The func-
tion of the well-studied lncRNA HOTAIR is similarly con-
troversial (62,86–88). Different targeting strategies to re-
move the same lncRNA in mice can also lead to some dif-
ferences in the cellular phenotypes (89,90). Together, these
results clearly demonstrate the challenges in characterizing
lncRNA function with existing LOF technologies. Such dis-
crepancies are not limited to lncRNAs, but have been ob-
served when depleting protein-coding genes using RNAi
and CRISPR-based methods as well as in high-throughput
screens (9,61,74,91,92).
The presence of method-specific off-target effects is
the most obvious explanation for the discrepancies be-
tween LOF methods. For RNAi, these effects are me-
diated through ‘microRNA-like’ mechanisms that result
in hybridisation and silencing of non-targeted transcripts
(29,93). For LNAs, oligonucleotides that hybridize to the
wrong transcript will inhibit its translation (for protein-
coding genes) or trigger its degradation (33). These
hybridisation-based mechanisms are supported by the fact
that many of our off-target effects for both RNAi and
LNA are sequence-dependent. (We note that a few genes
are up-regulated in our control comparisons; we hypothe-
size that this is due to regulatory relationships with down-
regulated genes that are directly bound by the siRNA or
LNA.) CRISPRi has fewer off-target effects associated with
the guide sequence; however, single cell cloning of dCas9–
KRAB-expressing cells in the absence of any guide causes a
strong transcriptional perturbation. This is probably driven
both by the founder effect of cloning as well as the con-
stitutive availability of the KRAB repressive domain in
the nucleus. It is also possible that dCas9–KRAB may use
endogenous small RNAs as guides. However, more com-
plex biological explanations for the discrepancies between
CRISPRi and the other methods cannot be ruled out, e.g.,
inhibition of transcription with CRISPRi may have cis ef-
fects that are not present upon depletion at the transcript
level with LNAs or RNAi.
To manage the off-target effects of the LOF methods in
functional studies, we recommend generating libraries or
assaying phenotypes from cells treated with multiple neg-
ative control sequences. This allows researchers to quan-
tify the sequence-dependent off-target effects for their ex-
perimental system, which are the most problematic as these
effects do not cancel out when comparing between nega-
tive control sequences and sequences against the targeted
gene. We also recommend the collection of data for nega-
tive controls obtained at each step of the method, e.g., un-
treated cells, cells treated with transfection reagent alone
(for RNAi/LNA) or cells expressing dCas9–KRAB with-
out the addition of guide sequence (for CRISPRi). This al-
lows accurate quantification of the extent of off-target ef-
fects introduced upon sequential manipulations in the LOF
protocol, which can alter the transcriptional or cellular
background in which the depletion occurs (potentially re-
sulting in different phenotypes). To our knowledge, this is
not common practice in the field, with the vast majority
of studies only using a single negative control sequence to
determine the molecular or cellular phenotype upon deple-
tion. In transcriptomic studies, genes affected by off-target
activity in the negative controls can be excluded from the
DE analysis in samples where the gene of interest has been
depleted, thus mitigating the impact of off-target effects
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Figure 6. Variation in the gene expression data across samples is driven by the LOFmethod and not by the identity of the gene being depleted. A principal
components analysis (PCA) was performed on the log-expression values of all samples, generated using the top 1000 genes with the lowest P-values in a
ANOVA-like comparison across all conditions. The top two principal components (PCs) are shown and the numbers in parentheses indicate the proportion
of variance explained by each axis. (A) PCA plot where each point is coloured by the LOF method used in the corresponding sample. (B) PCA plot where
each point is coloured by the gene to be depleted.
on the biological conclusions. Results should also be dis-
regarded if the number or log-fold changes of the off-target
genes are comparable to or greater than the number or log-
fold changes of DEGs detected upon knockdown of the tar-
get gene. In such cases, there is no meaningful way to dis-
tinguish between off-target effects and genuine downstream
targets of the gene of interest.
We also recommend performing differential expression
analyses with a minimum log-fold change threshold, to
avoid detecting genes with small changes in expression due
to off-target effects. The use of a threshold mitigates the
effect of non-specific activity on the differential expression
results for each LOF method, by focusing on larger and ar-
guably more biologically relevant effects of depletion. Obvi-
ously, a more stringent testing procedure will reduce power
to detect genuine downstream targets with small log-fold
changes. However, false negatives are generally of less con-
cern than false positives in DE analyses where hundreds
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to thousands of genes are routinely detected with signifi-
cant changes in expression. Indeed, genes with small log-
fold changes are challenging to validate and less appealing
for functional studies. This reduces the motivation for using
a more relaxed testing procedure, especially if more genes
are incorrectly detected due to off-target effects. The use of
a log-fold change threshold is fairly widespread in DE anal-
yses of RNA-seq data; nonetheless, in contexts where the
effects are known to be weak, one might decide to not use
any threshold to favour increasing the detection power over
reducing off-target effects.
Another strategy for reducing off-target effects is to use
multiple targeting sequences (e.g., multiple siRNAs, LNAs
or CRISPRi guides) against the gene of interest. Each se-
quence should target a different region of the gene, i.e., dif-
ferent exons for siRNAs, exons or introns for LNAs, and
different intervals in the promoter region for CRISPRi. Any
common effects across targeting sequences are likely to rep-
resent genuine biology of depletion of the gene of inter-
est, while sequence-specific effects can be attributed to off-
target activity. For example, the DEG sets that are gener-
ated after depletion with each targeting sequence can be in-
tersected to identify a reliable set of genuine downstream
targets (albeit with reduced detection power, due to the con-
servativeness of the intersection operation). A recent study
has recommended using multiple sequences to obtain a re-
producible molecular phenotype (73). We agree but note
that it is not always practical to obtain multiple targeting
sequences with high depletion efficiency for a gene of inter-
est. For example, our experience withMALAT1 shows that
only one out of five CRISPRi guides achieved over 50% de-
pletion efficiency, while forSLC25A25-AS1, only one out of
three LNA oligonucleotides achieved over 90% efficiency.
Other experimental factors can also be tuned to control
the extent of off-target activity in each LOF method. One
potential approach tominimize off-target effects is to titrate
the dose of reagents (from 1–30nM for LNAs and 1–50nm
for siRNAs) and use the lowest concentration that yields
satisfactory depletion of the target gene (16). This may re-
duce off-target effects by decreasing the opportunity for in-
correct hybridization to sequences other than the gene of
interest. Indeed, the use of the minimum dose has previ-
ously been encouraged (94) and is a prudent strategy for
improving the specificity of LOF methods in routine exper-
iments. It may also be informative to assay the molecular
and cellular phenotypes at earlier time points (e.g., 6–12
hours), which might reduce the off-target effects by mini-
mizing their propagation throughout regulatory networks.
However, this is dependent on the experimental context, as
later time points may still be necessary to fully characterize
the biological effects of depletion. Indeed, a recent study
that performed a CRISPRi screen on lncRNAs observed
cell growth defects 10–20 days after their depletion (14). In
such cases, even indirect off-target effects are problematic
and need to be considered when evaluating depletion speci-
ficity.
Another important aspect of functional studies is the
validation of molecular and cellular phenotypes with res-
cue experiments. This is usually done by overexpression
of the gene of interest to counter the effect of depletion,
e.g., for RNAi, transfection or transduction of exogenous
transcripts of the gene that have been modified to be re-
sistant to RNAi-mediated depletion. This ensures that the
proposed phenotype can be correctly attributed to the tar-
geted gene, regardless of the off-target effects of the deple-
tion method. We suggest that rescue experiments should be
routinely performed for validating gene function after its
depletion. However, some care is required during the design
of these rescue experiments to ensure that gene expression
is restored to physiological levels. Particular care needs to
be taken when overexpressing lncRNAs so that their intra-
cellular localization is preserved, as demonstrated for linc-
PINT (95).
We note that we have only considered a small subset of
possible LOF methods that are used by the research com-
munity. For RNAi, alternative methods include short hair-
pin RNAs (96), siPOOL (97) or C911 mismatch siRNAs
(98). In the case of LNAs, oligonucleotides can be designed
to target intronic regions of gene of interest (99). A vari-
ety of other CRISPR-based strategies are available, such as
whole locus or promoter deletion, insertion of transcrip-
tional termination sites into the gene body as well as the
CRISPR-Cas13 system (100). It remains to be seen whether
thesemethods have similar off-target effects to the protocols
we have studied here.
Modern LOF technologies allow researchers to deplete
any transcript of interest in a variety of biological systems,
and provide an essential experimental toolkit for studying
the biological function of transcripts and dissecting net-
works of transcriptional regulation. Here, we have empir-
ically formulated recommendations to minimize technical
artefacts and avoid––or at least prudently manage––the off-
target effects of these commonly used LOF methods.
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